GLYCOBIOLOGY MARKET ANALYSIS | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation



Read here the latest updates on the GLYCOBIOLOGY MARKET ANALYSIS published by CMI team. – PowerPoint PPT presentation

Number of Views:11
Date added: 4 August 2020
Slides: 13
Provided by: adwaitcoherent


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: GLYCOBIOLOGY MARKET ANALYSIS | Coherent Market Insights

Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//
  • Covid-19 Impact Tracker

  • Glycobiology Market, By Product Type
    (Instruments, Enzymes, Consumables, Reagents
    Kits), By Enzymes (Galactosidase (Fucosidases,
    Chitinases, Acetylgalactosaminidase, Heparinase,
    PNGase F, Others), GlcNAc Transferases
    (Acetylglucosaminyltransferase, Exostosin,
    Others), Fucosyltransferases, GalNAc
    Transferases, Galactosyl Transferases,
    Glucuronosyltransferases, Glucosyltransferases,
    Pentosyltransferases, Carbohydrate Kinases,
    Neuraminidases, Sialyltransferases, Others), By
    Application (Drug Discovery and Development
    Diagnostic Applications (Oncology, Immunology,
    Others), Industrial Application Therapeutic
    Application (Oncology, Immunology, Others),
    Others), By End User (Biopharmaceutical
    Companies, Research Laboratories, Hospitals,
    Diagnostic Centers, Contract Research
    Organizations, Biotechnology Industries, Academic
    Institutes, Others), and By Region (North
    America, Latin America, Europe, Asia Pacific,
    Middle East Africa) - Size, Share, Outlook, and
    Opportunity Analysis, 2019 - 2027

  • The term glycobiology is a branch of biology that
    deals with study of structure, function, and
    biosynthesis of saccharides (carbohydrates and
    carbohydrates containing molecules).
    Glycoconjugates is the general classification for
    carbohydrates covalently linked with other
    chemical species such as proteins, peptides,
    lipids and saccharides. Glycoconjugates and
    polysaccharides play a vital structural role in
    connective tissues.
  • Global Glycobiology Market Drivers
  • Glycans impact tumor proliferation, hematogenous
    metastasis, invasion and angiogenesis. Therefore,
    increasing prevalence of cancer is expected to
    propel growth of the global glycobiology market
    over the forecast period. For instance, according
    to the World Health Organization, around 18.1
    million new cases and 9.6 million deaths were
    registered due to cancer worldwide in 2018.
  • Moreover, high incidence of HIV/AIDS is also
    expected to aid in growth of the market. For
    instance, according to Joint United Nations
    Program on HIV/AIDS, 37.9 million people globally
    were living with HIV at the end of 2018.

  • Global Glycobiology Market Restraints
  • Complex structure of glycans is expected to
    hinder growth of the global glycobiology market.
    Unlike DNA or proteins, glycans do not have
    linear structure. Conventional sequence
    comparison methods cannot be applied directly to
    glycan comparison as structure and mechanism of
    glycans are completely different from DNA or
    proteins, which makes it more complex for
    analyzing. DNA or proteins have template
    sequences to synthesize primary structure, which
    are uniquely identified by template sequences.
    However, glycans do not have a template
    structure. Structure of glycan is determined by
    substrate specificity of glycosyl-transferases.
  • Moreover, high costs of spectrometry and high
    performance liquid chromatography are also
    expected to limit growth of the market.

  • Global Glycobiology Market Opportunities
  • RD in glycans is expected to offer lucrative
    growth opportunities for players in the global
    glycobiology market. For instance, in February
    2020, researchers from University of Minho,
    Portugal, reported development of a
    neurocompatible strategy to image temporal
    distribution of glycoproteins during neuronal
    development using Cu-free click chemistry.
  • Moreover, increasing focus on manufacturing
    anti-cancer drugs is also expected to aid in
    growth of the market. For instance, in January
    2020, researchers from Universidade do Porto,
    Portugal, reported assessment of the role of
    O-glycosylation using glycoengineered gastric
    cancer models in the detection of CD44v9 a
    major protein splice variant isoforms expressed
    in human gastrointestinal cancer cellsby
    monoclonal antibodies.
  • Enzymes segment in the global glycobiology market
    was valued at US 487.1 Mn in 2019 and is
    expected to reach US 1,371.0 Mn by 2027 at a
    CAGR of 13.6 during the forecast period.

Market Trends/Key Takeaways
  • Increasing adoption of viscosupplementation and
    facial aesthetic using hyaluronic acid is aiding
    growth of the market. Hyaluronan, a natural
    occurring glycosaminogen, is used in
    viscosupplementation and tissue fillers for
    volume restoration in facial rejuvenation.
  • Replacement of conventional glycoanalysis
    approaches with advanced techniques is also
    boosting growth of the market. Conventional
    methods for analysis of glycoforms in complex
    glycoproteins such as gel electrophoresis and
    elemental analysis are rapidly getting replaced
    by new approaches such as nuclear magnetic
    resonance (NMR) spectroscopy and mass
    spectrometry (MS).


Global Glycobiology Market Competitive Landscape
  • Major players operating in the global
    glycobiology market include, Merck KGaA,
    Bio-Techne Corporation, Bruker Corporation,
    Thermo Fisher Scientific, Inc., Shimadzu
    Corporation, Plexera Bioscience LLC, New England
    Biolabs Inc., Agilent Technologies, Inc., and
    ProZyme, Inc.
  • Global Glycobiology Market Key Developments
  • Major players in the market are focused on
    adopting various marketing strategies to expand
    their customer base. For instance, in February
    2020, New England Biolabs demonstrated its next
    generation sequencing portfolio at 2020 Advances
    in Genome Biology and Technology (AGBT) General
    Meeting, held in the U.S.
  • Players in the market are also focused on
    adopting partnership strategies to expand their
    product portfolio. For instance, in November
    2019, MOBILion Systems, Inc. partnered with
    researchers at the University of Georgia, for RD
    in glycans and glycoproteins.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email

Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//